TGFβ1 has also been the object of intense investigation due to its pathological relevance for breast cancer [39,40] where it acts as a tumor suppressor in premalignant lesions and at later stages promotes metastasis through induction of epithelial-to-mesenchymal transition (EMT). The gene discussed is TGFB1; the disease is breast cancer.